FDA Adverse Event Other Summary report: N

ACUVUE OASYS WITH HYDRACLEAR PLUS

MDR report key: 1040335 · Received May 8, 2008

Report

Report Number
MW5006785
Event Type
Other
Date Received
May 8, 2008
Date of Event
May 25, 2007
Report Date
May 8, 2008
Manufacturer
VISTAKON, JOHNSON AND JOHNSON
Product Code
LPL
Adverse Event
Yes
Product Problem
Yes
Report Source
Voluntary report
Reporter Location
DC, US
Reporter Occupation
PATIENT

Narratives

Description of Event or Problem · 1

I BEGAN WEARING ACUVUE OASYS CONTACT LENSES IN 2006, AND THEY WERE GREAT! I HAD EYE STRAIN ISSUES RELATED TO EXTENDED COMPUTER USE, AND THEY REALLY HELPED. BUT THEN, A YEAR LATER IN 2007, I HAD MY PRESCRIPTION REFILLED, AND IN THE FOLLOWING 4 MONTHS OF USE, I SUFFERED FROM SWOLLEN LIDS, BLOODSHOT EYES, AND SENSITIVITY TO LIGHT, PLUS GUMMINESS AND SOME KIND OF DISCHARGE. I WENT TO MULTIPLE OPHTHALMOLOGISTS AND OPTOMETRISTS, WITH ONE WHO FINALLY NOTED THAT I HAD BUMPS UNDER MY EYELIDS, INDICATING AN ALLERGIC REACTION OF SOME KIND TO MY CONTACTS. I HAD BEEN DIAGNOSED WITH GPC, EKC, AND PRESCRIBED ZYLET. MY ORIGINAL OPTOMETRIST THEN SWITCHED ME TO FOCUS DAILIES - IN CASE THE PROBLEMS WERE CAUSED BY AN INFECTION. A YEAR LATER - NOW, 2008-, I DECIDED TO TRY THE OASYS AGAIN, SINCE THE DAILIES WERE MORE EXPENSIVE - AND AFTER THE FIRST DAY MY EYES ARE BEGINNING TO SHOW THE SAME SIGNS OF IRRITATION AND SENSITIVITY TO LIGHT. SO NOW, I'M SWITCHING BACK TO AVOID OASYS LENSES. I'VE NEVER HAD ANY EYE ISSUES UNTIL THE 2007 OASYS INCIDENT. THEY MUST HAVE CHANGED THEIR COMPOSITION OR UPPED THE SILICONE CONTENT OR SOMETHING. THE PRODUCT WAS GREAT AT FIRST, AND IS NOW EXTREMELY PROBLEMATIC. OTHER PEOPLE WITH PROBLEMS CAN BE FOUND. DATES OF USE: 2007. DIAGNOSIS OR REASON FOR USE: PRESCRIPTION CONTACT LENSES FOR -2.25. EVENT ABATED AFTER USE STOPPED: YES. EVENT REAPPEARED AFTER REINTRODUCTION: YES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACUVUE OASYS WITH HYDRACLEAR PLUS OASYS CONTACT LENSES LPL VISTAKON, JOHNSON AND JOHNSON 7 33905 56273 0 B005V6B39R

Patients

Seq Age Sex Outcome Treatment
1 23 YR Other